Predictive performance of a physiologically based pharmacokinetic model of busulfan in children.
about
Physiologically based pharmacokinetic and pharmacodynamic modeling in cancer drug development: status, potential and gaps.Modeling and simulation in pediatric drug therapy: Application of pharmacometrics to define the right dose for children.Physiologically Based Pharmacokinetic Modeling in Pediatric Oncology Drug Development.GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study.Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
P2860
Predictive performance of a physiologically based pharmacokinetic model of busulfan in children.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Predictive performance of a ph ...... model of busulfan in children.
@en
Predictive performance of a ph ...... model of busulfan in children.
@nl
type
label
Predictive performance of a ph ...... model of busulfan in children.
@en
Predictive performance of a ph ...... model of busulfan in children.
@nl
prefLabel
Predictive performance of a ph ...... model of busulfan in children.
@en
Predictive performance of a ph ...... model of busulfan in children.
@nl
P2093
P2860
P1476
Predictive performance of a ph ...... model of busulfan in children.
@en
P2093
Christian Diestelhorst
Georg Hempel
James Russell
Joachim Boos
S Bill Kangarloo
P2860
P304
P356
10.3109/08880018.2014.927945
P577
2014-07-09T00:00:00Z